Alx Oncology Holdings (ALXO) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Alx Oncology Holdings (ALXO) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,378.45% |
| 10 | Alx Oncology Holdings | 215.94 Mn | 215.94 Mn | - | 93.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.69% |
| Dec 31, 2025 | 6.18% |
| Sep 30, 2025 | 24.37% |
| Jun 30, 2025 | 88.53% |
| Mar 31, 2025 | 11.38% |
| Dec 31, 2024 | 48.25% |
| Sep 30, 2024 | 46.41% |
| Jun 30, 2024 | 2.09% |
| Mar 31, 2024 | -6.28% |
| Dec 31, 2023 | 45.69% |
| Sep 30, 2023 | 99.26% |
| Jun 30, 2023 | 99.41% |
| Mar 31, 2023 | 43.17% |
| Dec 31, 2022 | -162.70% |
| Sep 30, 2022 | -13,631.49% |
| Jun 30, 2022 | -96,919.77% |
| Mar 31, 2022 | 76.30% |
| Dec 31, 2021 | 264.72% |
| Sep 30, 2021 | -45.70% |
| Jun 30, 2021 | 42.21% |